Thomas Link, MD
Diagnostic Radiology · San Francisco, CANPI 1548203409
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $27,533 of the $27,533 with a category attached, or 100.0%. Pfizer accounts for 88.3% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2020 at $12,343 and has fallen 73.9% since, to $3,222 in 2023. Among diagnostic radiology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 3 payments — averaging $9177.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$24K
- Astrazeneca UK Limited$3K
Across 4 payments — averaging $21,378 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GE HealthCare$66K
- Insightec,ltd$19K
What the payments were for
- Consulting fees$27,533100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 2 | $24,311 |
| Astrazeneca UK Limited | 1 | $3,222 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STEGLATRO$24,311
How this compares
$27,533 in reported general payments places this provider in the 95th percentile of 3,537 diagnostic radiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other diagnostic radiology in San Francisco
- Yingbing WangSan Francisco$403K
- Derk PurcellSan Francisco$93K
- Jerome BarakosSan Francisco$93K
- Javier Villanueva-MeyerSan Francisco$87K
- Christopher HessSan Francisco$66K
- Kimberly KallianosSan Francisco$59K
- Murray ReicherSan Diego$10.5M
- Agnes SantosaSan Diego$884K
- Robert SuhLos Angeles$758K
- Jonathan ChungSan Diego$747K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.